Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Edward Q. Chang"'
Autor:
Mayinuer Maitituoheti, Emily Z. Keung, Ming Tang, Liang Yan, Hunain Alam, Guangchun Han, Anand K. Singh, Ayush T. Raman, Christopher Terranova, Sharmistha Sarkar, Elias Orouji, Samir B. Amin, Sneha Sharma, Maura Williams, Neha S. Samant, Mayura Dhamdhere, Norman Zheng, Tara Shah, Amiksha Shah, Jacob B. Axelrad, Nazanin E. Anvar, Yu-Hsi Lin, Shan Jiang, Edward Q. Chang, Davis R. Ingram, Wei-Lien Wang, Alexander Lazar, Min Gyu Lee, Florian Muller, Linghua Wang, Haoqiang Ying, Kunal Rai
Publikováno v:
Cell Reports, Vol 33, Iss 3, Pp 108293- (2020)
Summary: Histone methyltransferase KMT2D harbors frequent loss-of-function somatic point mutations in several tumor types, including melanoma. Here, we identify KMT2D as a potent tumor suppressor in melanoma through an in vivo epigenome-focused poole
Externí odkaz:
https://doaj.org/article/c36af48cd2dc464096d008d1f2795abf
Autor:
Timothy P. Heffernan, Angela L. Harris, Martin R. Tremblay, Connor A. Parker, Yongying Jiang, Robert A. Mullinax, Cross Jason, Jihai Pang, Qi Wu, Edward Q. Chang, Sonal Gera, Keith M. Wilcoxen, Paul G. Leonard, Zhen Liu, Jeffrey J. Kovacs, Erika Suzuki, Barbara Czako, Ningping Feng, Joseph R. Marszalek, Nakia D. Spencer, Pijus K. Mandal, Jason P Burke, Simon S. Yu, Keith Mikule, Faika Mseeh, Philip Jones, Giulio Draetta
Publikováno v:
Journal of Medicinal Chemistry. 63:9888-9911
Tumor-associated macrophages (TAMs) have a significant presence in the tumor stroma across multiple human malignancies and are believed to be beneficial to tumor growth. Targeting CSF1R has been proposed as a potential therapy to reduce TAMs, especia
Autor:
Ayush T. Raman, Ming Tang, Liang Yan, Emily Z. Keung, Guangchun Han, Maura Williams, Linghua Wang, Florian L. Muller, Wei Lien Wang, Amiksha Shah, Norman Zheng, Hunain Alam, Min Gyu Lee, Yu Hsi Lin, Christopher Terranova, Davis R. Ingram, Haoqiang Ying, Edward Q. Chang, Tara Shah, Shan Jiang, Samir B. Amin, Alexander J. Lazar, Elias Orouji, Mayinuer Maitituoheti, Jacob B. Axelrad, Kunal Rai, Nazanin Esmaeili Anvar, Mayura Dhamdhere, Sharmistha Sarkar, Sneha Sharma, Anand K Singh, Neha S. Samant
Publikováno v:
Cell Reports, Vol 33, Iss 3, Pp 108293-(2020)
Cell reports
Cell reports
SUMMARY Histone methyltransferase KMT2D harbors frequent loss-of-function somatic point mutations in several tumor types, including melanoma. Here, we identify KMT2D as a potent tumor suppressor in melanoma through an in vivo epigenome-focused pooled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d02072ce246e19287ad40b288974bded